LLY Eli Lilly and Company
$1,183.46
Eli Lilly and Company (LLY) is confirmed to report earnings on October 29, 2026, before the market open. The consensus earnings estimate is $9.80 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +0.8% since its last earnings release on August 5, 2026.
Eli Lilly Missed Expectations, Revises Guidance
Wednesday, August 5, 2026 · 6:45 AM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 29
Thursday · 6:45 AM ET
Earnings Whisper
-
vs $9.80
Rev est $22.08B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$1,182.40
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Eli Lilly and Company
Eli Lilly and Co is a drug manufacturing company. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.
Sector
Healthcare
Industry
Drug Manufacturers / Major
Held By 15 ETFs, by dollar flow
- BUZZ Vaneck Social Sentiment ETF
- BUZZ Vaneck Social Sentiment ETF
- OEF iShares S&P 100 ETF
- OEF iShares S&P 100 ETF
- XLG Invesco S&P 500 Top 50 ETF
- XT iShares Exponential Technologies ETF
- XT iShares Exponential Technologies ETF
- XLG Invesco S&P 500 Top 50 ETF
- IOO iShares Global 100 ETF
- IOO iShares Global 100 ETF
- BGRO iShares Large Cap Growth Active ETF
- BGRO iShares Large Cap Growth Active ETF
- XLV Health Care Select Sector SPDR Fund
- XLV Health Care Select Sector SPDR Fund
- PPH VanEck Pharmaceutical ETF
Charts powered in part by Lightweight Charts™ by TradingView.